You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

cobimetinib

( KOE bi ME ti nib )
Funding:
Exceptional Access Program
  • cobimetinib - For combination therapy (with vemurafenib) for the treatment of patients with previously untreated BRAF V600 mutation-positive unresectable stage III or IV melanoma
Other Name(s): Cotellic™ ()
Appearance: tablet

Patient Info Sheet

Nov 2018

What it is used for

  • For treating a specific type of melanoma (skin cancer) that has spread to other parts of the body and cannot be removed by surgery. 
    • It is usually used together with another anti-cancer medication called vemurafenib


You might also be interested in